Adamis, et al. “Increased Vascular . . . ” Am. J. Opthmal. 118(4): 445 (Oct. 1994). |
Aiello, et al., “Vascular Endothelial Growth . . . ” N.E.J.M. 331(22): 1480 (Dec. 1994). |
Blakemore, et al., Hum. Genet. 97(3): 369-74 (1996). |
Blakemore, et al., Arthritis Rheum. 37: 1380-85 (1994). |
Center for Disease Control an Prevention, the, “National Diabetes Fact Sheet” (Nov. 1995). |
Clark, et al., Nuc. Acids Res. 14: 7897 (1986); Erratum in Nuc. Acids Res. 15(2): 868 (1987). |
Clay et al., “Interleukin-1 receptor antagonist gene polymorphism association with lichen scleroses”, Hum. Genet. 94: 407-410 (1994). |
Clay et al., “Novel interleukin-1 receptor antagonist exon polymorphisms and their use allele-specific mRNA assessment”, Human Genetics 97(6): 723-726 (Jun. 1996). |
Cork, et al., J. Invest. Dermatol. 104(5 Supp.): 15S-16S (1995). |
di Giovine et al., “Single base polymorphism at -511 in the human interleukin-1β gene (IL1β)”, Human Molecular Genetics 1(6):;410 Abstract only (1992). |
Dinarello, “Interleukin-1 and Interleukin-1 Antagonism” Blood 77: 1627 (1991). |
DRS Report No. 7 “A Modification of the . . . ” Invest. Opthalmol. Vis. Sci. 21: 210 (1981). |
DRS Report No. 8 “Photocoagulation Treatment of . . . ” Pthalmol. 88(7): 583 (1981). |
Duff, “Cytokines and Anti-Cytokines” Br. J. Rheumatol. 31(Supp. 1): 15 (1993). |
Duff, “Molecular Genetics of Cytokines”, The Cytokine Handbook (1994) 2nd ed., Chap. 2: 21-30. |
ETDRS No. 1, “Photocoagulation for diabetic Macula Edema” Arch. Opthamol. 103: 1796 (1993). |
ETDRS No. 9, “Early Coagulation . . . ” Opthalmol. 98: 766 (1991). |
ETDRS No. 12, “Fundus Photographic Risk . . . ” Opthalmol. 98: 823 (1991). |
Franks, et al . . . “Cytokines in Human . . . ” Current Eye Res. 11(Supp.): 187 (1992). |
Furutani et al., “Complete Nucleotide Sequence” Nuc. Acids Res. 14: 3167 (1992). |
Hu, et al., “Inhibition of Aniogenesis . . . ” Inflammation 18(1): 45 (1994). |
Hu & Fan “Protein Kinase C Inhibitor . . . ” Inflammation 19(1): 39 (1995). |
Klein et al., “Self-Rates Health and Diabetes of Long Duration,” Diabetes Care, 21(2): 236-240 (Feb. 1998). |
Ko et al., “An (A-C)n Dinucleotide Repeat Polymorphic Marker at the 5′ End of the Aldose Reductase Gene is Associated With Early-Onset Diabetic Retinopathy in NIDDM Patients,” Diabetes 44:727-732 (1995). |
Mansfield et al., “Novel Genetic Association Between Ulcerative Colitis and the Anti-Inflammatory Cytokine Interleukin-1 Receptor Antagonist”, Gastroenterology 106: 637-642 (Mar. 1994). |
McCarren, “Genetics of Diabetes”, Publication American Diabetes Association, 1994. |
Murata, et al., “Vascular Endothelial Growth . . . ” Opthalmic Res. 27(1): 48 (1995). |
Nedospasov, et al., “Tandem Arrangement of Genes . . . ” Cold Spring Harbor Sympos. Quant. Biol. 60: 611 (1986). |
Nicklin, et al., Genomics 19: 382-4 (1994). |
Pe'er, et al., “Hypoxia-Induced Expression of . . . ” Lab. Invest. 72(6): 638 (Jun. 1995). |
Pfeiffer, et al., “Vascular Endothelial Growth . . . ” Dtsch. Med. Wochenschr. 120(42): 1453 (Oct. 1995). |
Pociot, et al., Eur. J. Clin. Invest. 22: 396-402 (1992). |
Richardson, et al., Invest. Opthalmol. 38(4): 3714 (1997). |
Seaquist, et al., “Familial Clustering of . . . ” N.E.J.M. 320: 1161 (1989). |
Tarlow, et al., J. Invest. Dermatol. 103: 387 (1994). |
Todd, “Genetic Control of . . . ” Immulol. Today 11:122 (1990). |
Verjans, et al., “Polymorphism of the TNF Region in . . . ” Rheum. Dis. Clin. North Am. 18: 177 (1992). |
Woolf, “Estimating the Relationship between Blood Groups & Disease” Annals Human Genet. 19: 251 (1955). |